FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2754887039> ?p ?o ?g. }

• W2754887039 abstract "Multiple sclerosis (MS) is the leading cause of chronic neurological disability in young adults. The clinical disease course of MS varies greatly between individuals, with some patients progressing much more rapidly than others, making prognosis almost impossible. We previously discovered that cytotoxic CD4+ T cells (CD4+ CTL), identified by the loss of CD28, are able to migrate to sites of inflammation and that they contribute to tissue damage. Furthermore, in an animal model for MS, we showed that these cells are correlated with inflammation, demyelination, and disability. Therefore, we hypothesize that CD4+ CTL drive progression of MS and have prognostic value. To support this hypothesis, we investigated whether CD4+ CTL are correlated with worse clinical outcome and evaluated the prognostic value of these cells in MS. To this end, the percentage of CD4+CD28null T cells was measured in the blood of 176 patients with relapsing-remitting MS (=baseline). Multimodal evoked potentials (EP) combining information on motoric, visual, and somatosensoric EP, as well as Kurtzke expanded disability status scale (EDSS) were used as outcome measurements at baseline and after 3 and 5 years. The baseline CD4+CD28null T cell percentage is associated with EP (P = 0.003, R2 = 0.28), indicating a link between these cells and disease severity. In addition, the baseline CD4+CD28null T cell percentage has a prognostic value since it is associated with EP after 3 years (P = 0.005, R2 = 0.29) and with EP and EDSS after 5 years (P = 0.008, R2 = 0.42 and P = 0.003, R2 = 0.27). To the best of our knowledge, this study provides the first direct link between the presence of CD4+ CTL and MS disease severity, as well as its prognostic value. Therefore, we further elaborate on two important research perspectives: 1° investigating strategies to block or reverse pathways in the formation of these cells resulting in new treatments that slow down MS disease progression, 2° including immunophenotyping in prediction modeling studies to aim for personalized medicine." @default.
• W2754887039 created "2017-09-25" @default.
• W2754887039 creator A5051450048 @default.
• W2754887039 creator A5061462867 @default.
• W2754887039 creator A5061826283 @default.
• W2754887039 creator A5065437335 @default.
• W2754887039 creator A5076078904 @default.
• W2754887039 creator A5088390671 @default.
• W2754887039 creator A5091395853 @default.
• W2754887039 date "2017-09-20" @default.
• W2754887039 modified "2023-10-16" @default.
• W2754887039 title "Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression" @default.
• W2754887039 cites W1524676540 @default.
• W2754887039 cites W1532000053 @default.
• W2754887039 cites W1550082935 @default.
• W2754887039 cites W1581763071 @default.
• W2754887039 cites W1764386432 @default.
• W2754887039 cites W1782280903 @default.
• W2754887039 cites W1927093897 @default.
• W2754887039 cites W1961329342 @default.
• W2754887039 cites W1964261536 @default.
• W2754887039 cites W1965997336 @default.
• W2754887039 cites W1975175488 @default.
• W2754887039 cites W1976958511 @default.
• W2754887039 cites W1977406411 @default.
• W2754887039 cites W1979047051 @default.
• W2754887039 cites W1980438889 @default.
• W2754887039 cites W1982495693 @default.
• W2754887039 cites W1982865105 @default.
• W2754887039 cites W1983657521 @default.
• W2754887039 cites W1990315135 @default.
• W2754887039 cites W1990869196 @default.
• W2754887039 cites W1994408928 @default.
• W2754887039 cites W1999785461 @default.
• W2754887039 cites W2003018647 @default.
• W2754887039 cites W2003460362 @default.
• W2754887039 cites W2005575963 @default.
• W2754887039 cites W2009219510 @default.
• W2754887039 cites W2009434289 @default.
• W2754887039 cites W2011854432 @default.
• W2754887039 cites W2016374131 @default.
• W2754887039 cites W2022303626 @default.
• W2754887039 cites W2046748764 @default.
• W2754887039 cites W2048332099 @default.
• W2754887039 cites W2053967595 @default.
• W2754887039 cites W2054479200 @default.
• W2754887039 cites W2054995049 @default.
• W2754887039 cites W2058583207 @default.
• W2754887039 cites W2060387930 @default.
• W2754887039 cites W2071969018 @default.
• W2754887039 cites W2072709175 @default.
• W2754887039 cites W2076178764 @default.
• W2754887039 cites W2089725271 @default.
• W2754887039 cites W2090226724 @default.
• W2754887039 cites W2097998535 @default.
• W2754887039 cites W2099253077 @default.
• W2754887039 cites W2104181255 @default.
• W2754887039 cites W2105481352 @default.
• W2754887039 cites W2113291839 @default.
• W2754887039 cites W2116886325 @default.
• W2754887039 cites W2122347714 @default.
• W2754887039 cites W2141130828 @default.
• W2754887039 cites W2141264905 @default.
• W2754887039 cites W2146764480 @default.
• W2754887039 cites W2155328952 @default.
• W2754887039 cites W2158109120 @default.
• W2754887039 cites W2167441884 @default.
• W2754887039 cites W2171953655 @default.
• W2754887039 cites W2188074886 @default.
• W2754887039 cites W2195436470 @default.
• W2754887039 cites W2216513663 @default.
• W2754887039 cites W2277816408 @default.
• W2754887039 cites W2282684999 @default.
• W2754887039 cites W2284327277 @default.
• W2754887039 cites W2329496890 @default.
• W2754887039 cites W2415782976 @default.
• W2754887039 cites W2527263120 @default.
• W2754887039 cites W2598318906 @default.
• W2754887039 doi "https://doi.org/10.3389/fimmu.2017.01160" @default.
• W2754887039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5611397" @default.
• W2754887039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28979263" @default.
• W2754887039 hasPublicationYear "2017" @default.
• W2754887039 type Work @default.
• W2754887039 sameAs 2754887039 @default.
• W2754887039 citedByCount "56" @default.
• W2754887039 countsByYear W27548870392018 @default.
• W2754887039 countsByYear W27548870392019 @default.
• W2754887039 countsByYear W27548870392020 @default.
• W2754887039 countsByYear W27548870392021 @default.
• W2754887039 countsByYear W27548870392022 @default.
• W2754887039 countsByYear W27548870392023 @default.
• W2754887039 crossrefType "journal-article" @default.
• W2754887039 hasAuthorship W2754887039A5051450048 @default.
• W2754887039 hasAuthorship W2754887039A5061462867 @default.
• W2754887039 hasAuthorship W2754887039A5061826283 @default.
• W2754887039 hasAuthorship W2754887039A5065437335 @default.
• W2754887039 hasAuthorship W2754887039A5076078904 @default.
• W2754887039 hasAuthorship W2754887039A5088390671 @default.
• W2754887039 hasAuthorship W2754887039A5091395853 @default.
• W2754887039 hasBestOaLocation W27548870391 @default.

• next